IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Portfolio Profile

CIK: 0001844645 | SAN FRANCISCO, CA

Investment Profile

Style

GARP

Turnover

Medium

Orientation

Concentrated trader
$307.8M
AUM
13
Positions
95.12%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Vaxcyte Inc(PCVX)1,425,470$82.9M26.92%
2Arcutis Biotherapeutics Inc(ARQT)1,265,283$33.2M10.78%
3Trevi Therapeutics Inc(TRVI)1,742,672$32.5M10.56%
4Avalyn Pharmaceuticals Inc(AVLN)966,792$31.8M10.34%
5Evommune Inc(EVMN)1,926,943$25.6M8.32%
6

Sector Allocation

Latest filing, equity positions only

Healthcare74.19% · $228.3M
Unclassified25.81% · $79.4M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare78.62%74.19%-4.43%
Unclassified21.38%25.81%+4.43%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$250.7M | 13 pos.
$394.2M | 13 pos.
$155.6M | 11 pos.
$130.1M | 10 pos.
$168.5M | 11 pos.
$148.1M | 11 pos.
Maplight Therapeutics Inc(MPLT)
611,446
$21.9M
7.12%
7Oculis Holding AG(OCS)1,506,250$20.9M6.79%
8Bioage Labs Inc(BIOA)653,374$16.0M5.20%
9Immunome Inc(IMNM)732,512$15.5M5.04%
10Zenas Biopharma Inc(ZBIO)490,766$12.5M4.05%
Cap SizePrev %Curr %Change
Mid Cap45.65%42.74%-2.91%
Small Cap31.33%28.84%-2.49%
Unclassified21.38%25.81%+4.43%
Micro Cap1.64%2.61%+0.97%
$123.6M | 11 pos.
$161.3M | 12 pos.
$173.0M | 10 pos.
$258.7M | 12 pos.
$279.8M | 13 pos.
$307.8M | 13 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

1
New
1
Closed
3
Increased
4
Decreased
5
Unchanged